Clinical Trials Logo

Clinical Trial Summary

The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00195286
Study type Observational
Source Wyeth is now a wholly owned subsidiary of Pfizer
Contact
Status Completed
Phase Phase 4
Start date June 2004
Completion date July 2007

See also
  Status Clinical Trial Phase
Terminated NCT00560924 - Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women Phase 3
Recruiting NCT02658903 - Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter Phase 1